Nasus Pharma Ltd Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Nasus Pharma Ltd (NSRX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $29.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-25
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $29.00K 20-F · filed 2026-03-25 |